Product Information
TRI-LO-MARZIA TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.1049 per EA under NDC 68180083773. Its NADAC has been published 334 times since Feb 5, 2020.
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180083773
Classification
Generic
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA200541On Market Since
1/8/2020
Price Statistics
The NADAC for TRI-LO-MARZIA TABLET has been published 334 times since Feb 5, 2020, and over the history we have for it it has declined 50.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1049 per EA |
|---|---|
| All-time high | $0.2385 (Aug 12, 2020) |
| All-time low | $0.0903 (Nov 20, 2024) |
| 52-week high | $0.1162 |
| 52-week low | $0.1049 |
| Median price | $0.1550 |
| Average price | $0.1499 |
| Largest weekly change | -27.8% (Apr 17, 2024) |
| Weeks tracked | 334 |
| Tracking since | Feb 5, 2020 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TRI-LO-MARZIA TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRI-LO-MARZIA TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.1049 per EA (NDC 68180083773), effective Jun 24, 2026.
How has the price of TRI-LO-MARZIA TABLET changed over time?
Over the history we have for it, the NADAC for TRI-LO-MARZIA TABLET has declined 50.2%. It has been tracked across 334 weekly CMS publications since Feb 5, 2020.
What are the highest and lowest recorded NADAC prices for TRI-LO-MARZIA TABLET?
Since Feb 5, 2020, the NADAC for TRI-LO-MARZIA TABLET has ranged from a low of $0.0903 (Nov 20, 2024) to a high of $0.2385 (Aug 12, 2020), with a median of $0.1550 per EA.
Are there cheaper alternatives to TRI-LO-MARZIA TABLET?
7 NADAC-published products share the same active ingredient, strength, and dosage form as TRI-LO-MARZIA TABLET, but none are currently priced below it.
Who manufactures TRI-LO-MARZIA TABLET?
TRI-LO-MARZIA TABLET (NDC 68180083773) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification